Chlorpyrifos has undergone dramatic changes in its market trajectory, from a blockbuster proprietary molecule to a globally traded generic active ingredient. AgriBusiness Global spoke with Ram ...

Cuban said the high fees the FDA charges to approve generic drugs are a major barrier to manufacturing lower-priced generics in the United States, according to the report. Cuban said Cost Plus Drugs, ...

Cuban urges FDA fee waiver to boost US generics manufacturing Cost Plus Drugs plans to boost US production if fees are waived FDA charges $360,000 per generic drug approval application Trump promised ...

Generic store brand groceries can increasingly be found in the pantries, fridges, and freezers of Americans across all income groups. Once designed to communicate value and affordability, a new ...

ThioJoe breaks down generic Windows product keys and whether they’re legal or safe for you. Iran reacts to Trump administration seizing Venezuelan oil tanker La Niña likely for next month, NOAA says.

A new analysis has raised concerns about the Cigna Group’s drug pricing strategy, finding that one of its subsidiaries, Quallent Pharmaceuticals, often charges more for generic medications than ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

October 7, 2025 - Last week, Senator Josh Hawley released the following: Today, U.S. Senator Josh Hawley (R-Mo.) sent a letter to Food and Drug Administration (FDA) Commissioner Marty Makary following ...

Gilead Sciences, Inc. (NASDAQ:GILD) on Monday entered into settlement agreements to resolve the patent litigations with Lupin Ltd., Cipla Ltd. and Laurus Labs Ltd., generic manufacturers that filed ...

This latest FDA program aims to provide speedier reviews for generic drugmakers who produce their products in the U.S. Keeping up its string of pilots in recent months, the FDA on Friday unwrapped a ...

Following CapVest Partners' takeover of Germany’s Stada earlier this month, another private equity group is looking to cash in on Europe’s generic medicines manufacturing scene. Chicago-based ...